Randomized Controlled Trial of the Smart O2O Model Development for Chronic Diseases Management Through Digital Health

NANot yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
HypertensionDiabete Mellitus
Interventions
BEHAVIORAL

O2O digital healthcare service

The O2O service includes a mobile app and web-based portal that allows patients to monitor their blood glucose levels, track their medication use and physical activity, receive personalized feedback and education, and communicate with healthcare providers. The treatment group will receive a blood sugar checker and blood pressure checker that send the records automatically to the application through Bluetooth.

All Listed Sponsors
collaborator

Korea Health Industry Development Institute

OTHER_GOV

collaborator

Seoul National University

OTHER

lead

Seoul National University Hospital

OTHER

NCT06150508 - Randomized Controlled Trial of the Smart O2O Model Development for Chronic Diseases Management Through Digital Health | Biotech Hunter | Biotech Hunter